PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

FDA-approved drugs could make nano-medicine safer, study finds

A study led by researchers at the University of Colorado Anschutz Medical Campus looks to improve access to life-saving therapies for more patients

2025-07-09
(Press-News.org) An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, by using drugs already approved by the FDA for unrelated conditions.

The study was published today in Science Advances.

Their research suggests that repurposing existing medications can reduce harmful immune responses associated with nanoparticles. These ultra-small particles are designed to deliver treatments with precision but, in some cases, the immune system can react adversely.

“Nanoparticles are powerful tools in medicine, but the body often recognizes them as threats,” said Dmitri Simberg, PhD, co-director and professor at the Colorado Center for Nanomedicine and Nanosafety at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz and lead author of the study. “We found that certain existing drugs used for immune-related conditions can help mitigate these reactions.”

When introduced into the body for therapy or imaging, nanoparticles can trigger inflammation and other immune-related side effects. This occurs when the immune system, particularly the complement system, a group of blood proteins responsible for detecting potential threats, mistakenly targets helpful nanoparticles.

“This system is crucial for fighting infections, but it can become overactive in response to nanomedicine,” Simberg explained.

These overreactions may cause symptoms such as skin rashes, respiratory distress, cardiovascular problems or serious anaphylactic reactions. To address this, the team tested immune-modulating compounds that inhibit complement activation, aiming to reduce immune attacks on nanoparticles without broadly weakening the immune system.

Among the drugs tested in blood samples, iptacopan, currently approved to treat certain rare blood, nerve, and kidney disorders, was notably effective in blocking complement activity and minimizing adverse effects.

“We were impressed by how well iptacopan performed in preclinical animal models and some human samples,” said Simberg. “It not only reduced immune responses but also prevented more severe symptoms.”

The researchers also noted considerable variability in how individuals respond to nanoparticle-based treatments, often depending on specific ingredients used. This highlights the importance of personalized approaches to nanomedicine.

“We still need to understand which patients are at higher risk of allergic or inflammatory reactions, in order to apply immune modulating drugs during nanomedicine treatment,” Simberg added.

Simberg said the findings open the door to broader and safer applications of nanomedicine for diseases such as cancer, infections and genetic conditions.

“If we can manage the body’s response more effectively, we can improve access to these life-saving therapies for a wider group of patients,” said Simberg.

The collaborative study involved scientists from both the University of Colorado Anschutz Medical Campus, Cardiff University, and Newcastle University in the United Kingdom.

 

About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at

the forefront of transformative science, medicine, education and patient care. The

campus encompasses the University of Colorado health professional schools, more than 60

centers and institutes and two nationally ranked independent hospitals - UCHealth University

of Colorado Hospital and Children's Hospital Colorado – which see more than two million

adult and pediatric patient visits yearly. Innovative, interconnected and highly collaborative,

the CU Anschutz Medical Campus delivers life-changing treatments, patient care and

professional training and conducts world-renowned research fueled by $910 million in annual

research funding, including $757 million in sponsored awards and $153 million in

philanthropic gifts.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Many seafloor fish communities are retaining their individuality despite human impacts

2025-07-09
Despite widespread human impacts to wildlife diversity worldwide, many fish communities on the seafloor have maintained their uniqueness, reports a new study led by Zoë Kitchel, formerly of Rutgers University, and colleagues, published July 9 in the open-access journal PLOS Climate.  Around the world, humans have transformed ecosystems through development, hunting and fishing, invasive species and climate change. On land and in freshwater ecosystems, these changes have typically led to a process called homogenization, where the types ...

Somali women’s perspectives on female genital mutilation and its abandonment

2025-07-09
Somali women describe a complex and shifting tradition of female genital mutilation/cutting (FGM/C) in Somalia, according to a study published July 9, 2025 in the open-access journal PLOS Global Public Health by Zamzam I.A. Ali from the London School of Hygiene and Tropical Medicine, UK and the Mayo Clinic, US, and colleagues.  Female genital mutilation/cutting, which increases the risks of immediate and long-term psychological, obstetric, genitourinary and sexual and reproductive health complications, has no health benefits. It continues to be a human rights issue globally, with the UN and the Human Rights Council calling for a complete end to the practice. ...

Structure of tick-borne virus revealed at atomic resolution for the first time

2025-07-09
UNIVERSITY PARK, Pa. — As summer kicks into full gear and people are spending more time outside, there’s one thing on many people’s minds — ticks. Tick season is starting earlier and lasting longer, and ticks are popping up in areas they haven’t been found before, expanding the risk of tick-borne viruses. One emerging tick-borne virus in North America — including in Pennsylvania — is the Powassan virus (POWV), which can cause encephalitis, seizures, paralysis and ...

The robot will see you now

2025-07-09
As waiting rooms fill up, doctors get increasingly burnt out, and surgeries take longer to schedule and more get cancelled, humanoid surgical robots offer a solution. That’s the argument that UC San Diego robotics expert Michael Yip makes in a perspective piece out July 9 in Science Robotics.  Why? Today’s surgical robots are costly pieces of equipment designed for specialized tasks and can only be operated by highly trained physicians. However, this model doesn’t scale. Despite the drastic improvements in artificial intelligence and autonomy for industrial and humanoid robots in the past year, these improvements haven’t ...

Stepping up the potential of wearables: predicting pediatric surgery complications

2025-07-09
An estimated 4 million children undergo surgical procedures in hospitals across the United States each year. Although postoperative complications, such as infections, can pose significant health risks to kids, timely detection following hospital discharge can prove challenging.   A new study published in Science Advances — and led by researchers at Shirley Ryan AbilityLab, the Ann and Robert H. Lurie Children’s Hospital of Chicago and University of Alabama at Birmingham — is the first to use consumer wearables to quickly and precisely predict postoperative complications in children and shows potential for facilitating faster treatment ...

Prenatal and childhood lead exposure linked to faster memory decay in children

2025-07-09
New York, NY — July 9, 2025 — A study led by researchers at the Icahn School of Medicine at Mount Sinai shows that exposure to lead during pregnancy and early childhood may accelerate the rate at which children forget information—a critical marker of memory impairment that may have implications for learning and development. Using delayed matching-to-sample task (DMTS)—a cognitive task that can be used to evaluate underlying neurobehavioral functions, such as attention and working memory, and has been demonstrated to be sensitive to metal neurotoxicants—the study examined how both prenatal ...

Medical needles in the hands of AI

2025-07-09
Imagine a physician attempting to reach a cancerous nodule deep within a patient's lung – a target the size of a pea, hidden behind a maze of critical blood vessels and airways that shift with every breath. Straying one millimeter off course could puncture a major artery, and falling short could mean missing the cancer entirely, allowing it to spread untreated.  This is the high-stakes reality physicians face in thousands of procedures daily, where accuracy is critical and the task is complicated by anatomical obstacles that are non-penetrable or sensitive. Can artificial intelligence (AI) and robots help address these challenges and ...

Source criticism in school requires more than isolated interventions

2025-07-09
Strengthening school students’ resilience to disinformation requires more than isolated interventions on source criticism. A new study from Uppsala University shows that short teaching interventions on disinformation have no long-term effect on upper secondary school students’ ability to distinguish between credible and misleading news. The results are now published in the scholarly journal PLOS One and are based on a study of 459 Swedish upper secondary school students. The study, supported by the Swedish Institute ...

Mount Sinai’s Andy Jagoda, MD, receives top honor from New York chapter of the American College of Emergency Physicians

2025-07-09
Andy Jagoda, MD, Professor of Emergency Medicine at the Icahn School of Medicine of Mount Sinai, has received the prestigious Edward W. Gilmore Lifetime Achievement Award from the New York Chapter of the American College of Emergency Physicians (ACEP). He was presented with this honor Wednesday, July 9, at the New York ACEP Scientific Assembly in Bolton Landing, New York. This award honors Dr. Jagoda for his significant contributions to the field through education, leadership, mentoring, and advancing the quality of emergency care. It recognizes Dr. Jagoda’s lifelong commitment to, and lasting impact on, the specialty of emergency medicine ...

Clinical trials reveal promising alternatives to highly toxic tuberculosis drug

2025-07-09
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in the treatment of drug-resistant TB. The findings were published on July 8, 2025, in two peer-reviewed articles in The Lancet Infectious Diseases, one of the world’s leading journals in the field of infectious disease medicine. Research partners in Germany included the German Center for Infection Research (DZIF), Munich, ...

LAST 30 PRESS RELEASES:

Orange is the new aphrodisiac—for guppies

Murals boost Cincinnati’s vitality, community development

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Verbal response time reveals hidden sleepiness in older adults

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes

From injury to agony: Scientists discover brain pathway that turns pain into suffering

Molecular simulations show graphite ‘hijacks’ diamond formation through unexpected crystallization pathways

Scientific breakthrough uses cold atoms to unlock cosmic mysteries 

First-of-its-kind journal facilitates rapid publication of AI research

AI tool helps improve detection of cardiac amyloidosis

Loneliness predicts poor mental and physical health outcomes

Keeping the photon in the dark

FDA-approved drugs could make nano-medicine safer, study finds

Many seafloor fish communities are retaining their individuality despite human impacts

Somali women’s perspectives on female genital mutilation and its abandonment

Structure of tick-borne virus revealed at atomic resolution for the first time

The robot will see you now

Stepping up the potential of wearables: predicting pediatric surgery complications

Prenatal and childhood lead exposure linked to faster memory decay in children

Medical needles in the hands of AI

Source criticism in school requires more than isolated interventions

Mount Sinai’s Andy Jagoda, MD, receives top honor from New York chapter of the American College of Emergency Physicians

Clinical trials reveal promising alternatives to highly toxic tuberculosis drug

[Press-News.org] FDA-approved drugs could make nano-medicine safer, study finds
A study led by researchers at the University of Colorado Anschutz Medical Campus looks to improve access to life-saving therapies for more patients